• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽喉镜检查在慢性咽炎严重程度分级中的应用及其在评估咽腔磨削术治疗效果中的应用

Use of Nasopharyngoscopy Severity Classification of Chronic Epipharyngitis and Its Application for Evaluating the Treatment Outcomes of Epipharyngeal Abrasive Therapy.

作者信息

Ohno Yoshihiro

机构信息

Otolaryngology, Ohno ENT Clinic, Tokyo, JPN.

出版信息

Cureus. 2024 Feb 12;16(2):e54067. doi: 10.7759/cureus.54067. eCollection 2024 Feb.

DOI:10.7759/cureus.54067
PMID:38348201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10860666/
Abstract

Background Chronic epipharyngitis causes postnasal drip, pharyngeal pain, pharyngeal discomfort, headache, and shoulder stiffness. Additionally, autonomic nervous system symptoms such as dizziness, general fatigue, and sleeplessness may occur. It can also contribute to the development of focal diseases. Although epipharyngeal abrasive therapy (EAT) is effective for chronic epipharyngitis involving the abrasion of the epipharynx with a zinc chloride solution, there is a lack of clear diagnostic criteria, and treatment outcomes are rarely reported. Methodology A classification of the severity of chronic epipharyngitis was attempted in 154 cases based on nasopharyngeal endoscopic findings, with a subsequent examination of treatment outcomes using EAT. Diagnosis of chronic epipharyngitis involved identifying redness, swelling, postnasal drip, and crusting of the epipharyngeal mucosa. Severity classification relied on a four-point scale measuring the degree of redness and swelling, with additional points assigned for the presence of postnasal drip and crusting. This classification also served as a criterion for judging treatment effectiveness. The prevalence and improvement rate of black spots and granular changes were assessed through nasopharyngeal endoscopy with narrow-band imaging. Subjective symptoms were evaluated using before and after treatment questionnaires, employing a four-point scale for symptoms commonly associated with chronic epipharyngitis (headache, postnasal drip, nasal obstruction, pharyngeal discomfort, pharyngeal pain, shoulder stiffness, tinnitus, ear fullness, dizziness, cough, and sputum). A 10-point numerical rating scale (NRS) was used to assess the physical condition. Results Following EAT, the severity of nasopharyngeal endoscopic findings notably improved, with a 76.0% (117/154) improvement rate (remarkable improvement: 19.5% (30), improvement: 56.5% (87)). The improvement rate for the chief complaint reached 85.7% (132/154), demonstrating significant enhancement in the score for each symptom. NRS scores also improved at a rate of 76.0% (117/154). A significant correlation was observed between the improvement in local findings and chief complaints. The prevalence of black spots and granular changes before EAT was 83.8% (129/154) and 64.3% (99/154), exhibiting improvement rates of 65.9% (87/132) and 54.8% (57/104), respectively. Conclusions Nasopharyngeal endoscopy proves valuable for diagnosing and assessing the severity of chronic epipharyngitis, as well as evaluating treatment effectiveness. The findings indicate that EAT is an effective treatment for chronic epipharyngitis, with improvements in local findings correlating with enhancements in the chief complaint. This underscores the importance of employing aggressive EAT in managing patients with chronic epipharyngitis.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/fcd5da8a0b8b/cureus-0016-00000054067-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/421797513b3f/cureus-0016-00000054067-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/d6901f18c9da/cureus-0016-00000054067-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/9db8347ea2e5/cureus-0016-00000054067-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/e6cac8058fa2/cureus-0016-00000054067-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/58443bf92442/cureus-0016-00000054067-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/fcd5da8a0b8b/cureus-0016-00000054067-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/421797513b3f/cureus-0016-00000054067-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/d6901f18c9da/cureus-0016-00000054067-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/9db8347ea2e5/cureus-0016-00000054067-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/e6cac8058fa2/cureus-0016-00000054067-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/58443bf92442/cureus-0016-00000054067-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df2/10860666/fcd5da8a0b8b/cureus-0016-00000054067-i06.jpg
摘要

背景 慢性咽炎可导致鼻后滴漏、咽痛、咽部不适、头痛和肩部僵硬。此外,还可能出现自主神经系统症状,如头晕、全身乏力和失眠。它还可能促使局部疾病的发生。尽管咽上磨蚀疗法(EAT)对涉及用氯化锌溶液磨蚀咽上部位的慢性咽炎有效,但缺乏明确的诊断标准,且很少有治疗结果的报道。方法 基于鼻咽内镜检查结果,对154例慢性咽炎患者的严重程度进行分类,随后使用EAT检查治疗结果。慢性咽炎的诊断包括识别咽上黏膜的发红、肿胀、鼻后滴漏和结痂。严重程度分类依据一个四点量表来衡量发红和肿胀的程度,鼻后滴漏和结痂的存在会额外加分。该分类也作为判断治疗效果的标准。通过窄带成像鼻咽内镜评估黑点和颗粒状改变的发生率及改善率。使用治疗前后问卷评估主观症状,采用四点量表评估与慢性咽炎常见相关的症状(头痛、鼻后滴漏、鼻塞、咽部不适、咽痛、肩部僵硬、耳鸣、耳闷、头晕、咳嗽和咳痰)。使用10分数字评定量表(NRS)评估身体状况。结果 EAT治疗后,鼻咽内镜检查结果的严重程度显著改善,改善率为76.0%(117/154)(显著改善:19.5%(30例),改善:56.5%(87例))。主要症状的改善率达到85.7%(132/154),各症状评分均有显著提高。NRS评分也以76.0%(117/154)的比例得到改善。局部检查结果的改善与主要症状之间存在显著相关性。EAT治疗前黑点和颗粒状改变的发生率分别为83.8%(129/154)和64.3%(99/154),改善率分别为65.9%(87/132)和54.8%(57/104)。结论 鼻咽内镜检查对于诊断和评估慢性咽炎的严重程度以及评估治疗效果具有重要价值。研究结果表明,EAT是治疗慢性咽炎的有效方法,局部检查结果的改善与主要症状的改善相关。这凸显了在慢性咽炎患者管理中积极采用EAT的重要性。

相似文献

1
Use of Nasopharyngoscopy Severity Classification of Chronic Epipharyngitis and Its Application for Evaluating the Treatment Outcomes of Epipharyngeal Abrasive Therapy.鼻咽喉镜检查在慢性咽炎严重程度分级中的应用及其在评估咽腔磨削术治疗效果中的应用
Cureus. 2024 Feb 12;16(2):e54067. doi: 10.7759/cureus.54067. eCollection 2024 Feb.
2
Outcome of an outpatient specialty clinic for chronic epipharyngitis.慢性咽炎专科门诊疗效观察。
Auris Nasus Larynx. 2021 Jun;48(3):451-456. doi: 10.1016/j.anl.2020.09.019. Epub 2020 Oct 13.
3
Exhaled nitric oxide levels are associated with the severity of chronic epipharyngitis and decreased via epipharyngeal abrasion.呼气一氧化氮水平与慢性悬雍垂炎的严重程度相关,并可通过悬雍垂磨蚀降低。
Auris Nasus Larynx. 2023 Aug;50(4):534-539. doi: 10.1016/j.anl.2022.11.003. Epub 2022 Dec 2.
4
Epipharyngeal Abrasive Therapy (EAT) Reduces the mRNA Expression of Major Proinflammatory Cytokine IL-6 in Chronic Epipharyngitis.咽上磨蚀疗法(EAT)降低慢性咽炎中主要促炎细胞因子 IL-6 的 mRNA 表达。
Int J Mol Sci. 2022 Aug 16;23(16):9205. doi: 10.3390/ijms23169205.
5
Epipharynegal Abrasive Therapy Downregulates the Number of Epipharyngeal Abrasive CD4 Cells With Symptomatic Recovery.咽后研磨疗法可下调伴有症状缓解的咽后研磨CD4细胞数量。
Cureus. 2023 Dec 10;15(12):e50288. doi: 10.7759/cureus.50288. eCollection 2023 Dec.
6
Autonomic Stimulation Action of EAT (Epipharyngeal Abrasive Therapy) on Chronic Epipharyngitis.咽上磨蚀疗法(EAT)对慢性咽炎的自主神经刺激作用
Cureus. 2024 Jun 26;16(6):e63182. doi: 10.7759/cureus.63182. eCollection 2024 Jun.
7
A Potential Novel Treatment for Chronic Cough in Long COVID Patients: Clearance of Epipharyngeal Residual SARS-CoV-2 Spike RNA by Epipharyngeal Abrasive Therapy.一种针对新冠后综合征患者慢性咳嗽的潜在新疗法:经咽上呼吸道磨蚀疗法清除咽上呼吸道残留的新冠病毒刺突RNA
Cureus. 2023 Jan 5;15(1):e33421. doi: 10.7759/cureus.33421. eCollection 2023 Jan.
8
Autonomic Nervous System Regulation Effects of Epipharyngeal Abrasive Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Associated With Chronic Epipharyngitis.咽上研磨疗法对与慢性咽炎相关的肌痛性脑脊髓炎/慢性疲劳综合征的自主神经系统调节作用
Cureus. 2023 Jan 14;15(1):e33777. doi: 10.7759/cureus.33777. eCollection 2023 Jan.
9
Epipharyngeal Abrasive Therapy (EAT) Has Potential as a Novel Method for Long COVID Treatment.咽上磨蚀疗法(EAT)有望成为治疗长新冠的新方法。
Viruses. 2022 Apr 27;14(5):907. doi: 10.3390/v14050907.
10
Differences Between Patients With Chronic Epipharyngitis With and Without Previous COVID-19 Infection.有过新冠病毒感染史和无新冠病毒感染史的慢性咽炎患者之间的差异
Cureus. 2024 Jan 2;16(1):e51543. doi: 10.7759/cureus.51543. eCollection 2024 Jan.

引用本文的文献

1
Retracted: Chronic Epipharyngitis Treated with Epipharyngeal Abrasion Therapy: Symptoms, Diagnosis, Pathogenesis, and Treatment Outcomes.撤回:咽上黏膜擦伤疗法治疗慢性咽炎:症状、诊断、发病机制及治疗结果
JMA J. 2025 Apr 28;8(2):371-384. doi: 10.31662/jmaj.2024-0437. Epub 2025 Mar 21.

本文引用的文献

1
The Effect of Epipharyngeal Abrasive Therapy (EAT) on the Baroreceptor Reflex (BR).咽上磨蚀疗法(EAT)对压力感受器反射(BR)的影响。
Cureus. 2023 Sep 12;15(9):e45080. doi: 10.7759/cureus.45080. eCollection 2023 Sep.
2
Epipharyngeal Abrasive Therapy (EAT) Reduces the mRNA Expression of Major Proinflammatory Cytokine IL-6 in Chronic Epipharyngitis.咽上磨蚀疗法(EAT)降低慢性咽炎中主要促炎细胞因子 IL-6 的 mRNA 表达。
Int J Mol Sci. 2022 Aug 16;23(16):9205. doi: 10.3390/ijms23169205.
3
Outcome of an outpatient specialty clinic for chronic epipharyngitis.
慢性咽炎专科门诊疗效观察。
Auris Nasus Larynx. 2021 Jun;48(3):451-456. doi: 10.1016/j.anl.2020.09.019. Epub 2020 Oct 13.
4
Chronic epipharyngitis: A missing background of IgA nephropathy.慢性咽炎:IgA肾病的一个被忽视的背景因素。
Autoimmun Rev. 2019 Aug;18(8):835-836. doi: 10.1016/j.autrev.2019.06.002. Epub 2019 Jun 7.
5
Structural and functional features of central nervous system lymphatic vessels.中枢神经系统淋巴管的结构和功能特征。
Nature. 2015 Jul 16;523(7560):337-41. doi: 10.1038/nature14432. Epub 2015 Jun 1.
6
Three or more routes for leukocyte migration into the central nervous system.白细胞迁移至中枢神经系统的三种或更多途径。
Nat Rev Immunol. 2003 Jul;3(7):569-81. doi: 10.1038/nri1130.